0 citations
Ropeginterferon Alfa-2b versus Standard Therapy for Polycythaemia Vera; a Randomised, Controlled, Phase III Trial
SSRN Electronic Journal2019
Citations Over Time
Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva, Miklós Egyed, Viktor Rossiev, Petr Ďulíček, Árpád Illés, Halyna Pylypenko, Lylia Sivcheva, Jiřı́ Mayer, Vera Yablokova, Kurt Krejcy, Barbara Grohmann-Izay, Hans Carl Hasselbalch, Róbert Královics, Jean‐Jacques Kiladjian, PROUD-PV Study Group
Related Papers
- → Do All Patients With Polycythemia Vera or Essential Thrombocythemia Need Cytoreduction?(2018)10 cited
- → Elevated Plasma <i>β</i>-Thromboglobulin Levels in Multiple Myeloma and in Polycythaemia vera(1979)12 cited
- → Treatment of Polycythaemia Vera(1967)
- [Development of polycythemia vera during chronic idiopathic myelofibrosis].(1985)
- → Acute coronary syndrome as initial presentation of polycythaemia Vera(2022)